Long-term effects of neonatal drugs on the kidney

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 23, Issue SUPPL. 3, 2010, Pages 87-89

  Zaffanello, Marco ^a   Bassareo, Pier Paolo ^b   Cataldi, Luigi ^c   Antonucci, Roberto ^d   Biban, Paolo ^e   Fanos, Vassilios ^b  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d Hospital Nostra Signora di Bonaria   (Italy)

^e Major City Hospital   (Italy)

Author keywords

drug; fetus; nephrotoxicity; pregnancy; Preterm infant

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMPHOTERICIN B DEOXYCHOLATE; AMPICILLIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; BETA LACTAM ANTIBIOTIC; BETAMETHASONE; CEFTRIAXONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GENTAMICIN; IBUPROFEN; INDOMETACIN; LOSARTAN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; ROFECOXIB; VANCOMYCIN; AMINOGLYCOSIDE; DRUG;

ACUTE KIDNEY FAILURE; ANURIA; CARDIOVASCULAR MALFORMATION; CENTRAL NERVOUS SYSTEM MALFORMATION; CHRONIC KIDNEY FAILURE; CONGENITAL MALFORMATION; FETUS DEVELOPMENT; FETUS DISEASE; HUMAN; HYPERKALEMIA; HYPOTENSION; INTRAUTERINE GROWTH RETARDATION; KIDNEY ANOMALY; KIDNEY DEVELOPMENT; KIDNEY DYSFUNCTION; KIDNEY INJURY; KIDNEY MALFORMATION; KIDNEY TUBULE ACIDOSIS; KIDNEY TUBULE DISORDER; NEPHROTOXICITY; NONHUMAN; OLIGOHYDRAMNIOS; OLIGURIA; POSTNATAL DEVELOPMENT; PREGNANCY; PREMATURITY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SIDE EFFECT; URINARY DYSFUNCTION; URINE VOLUME; ANIMAL; CHEMICALLY INDUCED DISORDER; EVALUATION; KIDNEY DISEASE; METHODOLOGY; NEWBORN; NEWBORN DISEASE; NEWBORN INTENSIVE CARE; TIME;

AMINOGLYCOSIDES; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INTENSIVE CARE, NEONATAL; KIDNEY DISEASES; PHARMACEUTICAL PREPARATIONS; TIME FACTORS;

EID: 77957952633     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2010.501156     Document Type: Review

References (23)

1. Cataldi L, Leone R, Moretti U, De Mitri B, Fanos V, Ruggeri L, Sabatino G, Torcasio F, Zanardo V, Attardo G, et al. Potential risk factors for the development of acute renal failure in preterm newborn infants: a case-control study. Arch Dis Child Fetal Neonatal Ed 2005;90:F514-F519.
2. Puddu M, Fanos V, Podda F, Zaffanello M. The kidney from prenatal to adult life: perinatal programming and reduction of number of nephrons during development. Am J Nephrol 2009;30:162-170.
3. Nathanson S, Moreau E, Merlet-Benichou C, Gilbert T. In utero and in vitro exposure to b-lactams impair kidney development in the rat. J Am Soc Nephrol 2000;11:874-884.
4. Kent AL, Maxwell LE, Koina ME, Falk MC, Willenborg D, Dahlstrom JE. Renal glomeruli and tubular injury following indomethacin, ibuprofen, and gentamicin exposure in a neonatal rat model. Pediatr Res 2007;62:307-312.
5. Dieterich C, Puey A, Lin S, Swezey R, Furimsky A, Fairchild D, Mirsalis JC, Ng HH. Gene expression analysis reveals new possible mechanisms of vancomycin-induced nephrotoxicity and identifies gene markers candidates. Toxicol Sci 2009;107:258-269.
6. Loria A, Reverte V, Salazar F, Saez F, Llinas MT, Salazar FJ. Changes in renal hemodynamics and excretory function induced by a reduction of ANG II effects during renal development. Am J Physiol Regul Integr Comp Physiol 2007;293:R695-R700.
7. Coleman CM, Minor JJ, Burt LE, Thornhill BA, Forbes MS, Chevalier RL. Angiotensin AT1-receptor inhibition exacerbates renal injury resulting from partial unilateral ureteral obstruction in the neonatal rat. Am J Physiol Renal Physiol 2007;293:F262-F268.
8. Hasan J, Beharry KD, Gharraee Z, Stavitsky Y, Abad-Santos P, Abad-Santos M, Aranda JV, Modanlou HD. Early postnatal ibuprofen and indomethacin effects in suckling and weanling rat kidneys. Prostaglandins Other Lipid Mediat 2008;85:81-88.
9. Sáez F, Reverte V, Salazar F, Castells MT, Llinás MT, Salazar FJ. Hypertension and sex differences in the age-related renal changes when cyclooxygenase-2 activity is reduced during nephrogenesis. Hypertension 2009;53:331-337.
10. Moritz KM, Singh RR, Probyn ME, Denton KM. Developmental programming of a reduced nephron endowment: more than just a baby s birth weight. Am J Physiol Renal Physiol 2009;296:F1-F9.
11. Zhang J, Massmann GA, Rose JC, Figueroa JP. Differential effects of clinical doses of antenatal betamethasone on nephron endowment and glomerular filtration rate in adult sheep. Reprod Sci 2010;17:186-195.
12. Gubhaju L, Sutherland MR, Yoder BA, Zulli A, Bertram JF, Black MJ. Is nephrogenesis affected by preterm birth? Studies in a non-human primate model. Am J Physiol Renal Physiol 2009;297:F1668-F1677.
13. Schreuder MF, Wilhelm AJ, Bökenkamp A, Timmermans SM, Delemarre-van de Waal HA, van Wijk JA. Impact of gestational age and birth weight on amikacin clearance on day 1 of life. Clin J Am Soc Nephrol 2009;4:1774-1778.
14. Puddu M, Podda MF, Mussap M, Tumbarello R, Fanos V. Early detection of microalbuminuria and hypertension in children of very low birthweight. J Matern Fetal Neonatal Med 2009;22:83-88.
15. Zaffanello M, Brugnara M, Bruno C, Franchi B, Talamini G, Guidi G, Cataldi L, Biban P, Mella R, Fanos V. Renal function and volume of infants born with a very low birthweight: a preliminary cross-sectional study. Acta Paediatr, in press.
16. Cuzzolin L, Fanos V, Pinna B, di Marzio M, Perin M, Tramontozzi P, Tonetto P, Cataldi L. Postnatal renal function in preterm newborns: a role of diseases, drugs and therapeutic interventions. Pediatr Nephrol 2006;21:931-938.
17. Boubred F, Vendemmia M, Garcia-Meric P, Buffat C, Millet V, Simeoni U. Effects of maternally administered drugs on the fetal and neonatal kidney. Drug Saf 2006;29: 397-419.
18. Shrim A, Berger H, Kingdom J, Hamoudi A, Shah PS, Koren G. Prolonged exposure to angiotensin-converting enzyme inhibitors during pregnancy. Fetal toxicity could be reversible. Can Fam Physician 2005;51:1335-1337.
19. Cooper WO, Hernandez-Diaz S, Arbogast PG, Dudley JA, Dyer S, Gideon PS, Hall K, Ray WA. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 2006;354:2443-2451.
20. Alwan S, Polifka JE, Friedman JM. Angiotensin II receptor antagonist treatment during pregnancy. Birth Defects Res A Clin Mol Teratol 2005;73:123-130.
21. Holler B, Omar SA, Farid MD, Patterson MJ. Effects of fluid and electrolyte management on amphotericin B-induced nephrotoxicity among extremely low birth weight infants. Pediatrics 2004;113:e608-e616.
22. Turcu R, Patterson MJ, Omar S. Influence of sodium intake on amphotericin B-induced nephrotoxicity among extremely premature infants. Pediatr Nephrol 2009;24:497-505.
23. Solhaug MJ, Bolger PM, Jose PA. The developing kidney and environmental toxins. Pediatrics 2004;113: 1084-1091.